BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
12/10/18 Otsuka (4768:JP) Dacogen for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
12/10/18 Menlo Therapeutics (MNLO) Serlopitant for Pruritus Subscribers Only Subscribers Only Subscribers Only
12/10/18 Vanda (VNDA) Hetlioz for Smith-Magenis Syndrome Subscribers Only Subscribers Only Subscribers Only
12/7/18 AstraZeneca (AZN) Imfinzi for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only
12/7/18 Acacia Pharma (ACPH:BB) Barhemsys for Emesis Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
12/11/18 Subscribers Only Subscribers Only Trial Data - Updated Results
12/11/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
12/11/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
12/11/18 Subscribers Only Subscribers Only Company - Analyst/R&D Update
Now - 12/12/18 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)